Join us for an exciting virtual salon

Sara Demy, CEO of Demy-Colton, hosts interactive virtual salons featuring industry leaders and distinguished guests exploring today’s most consequential and disruptive topics in healthcare.

Strategic Pricing: Optimizing product valuation by avoiding bias and thinking locally
Price is one of the three key variables in the profit function, a critical negotiation point prior to patient access, and a component of the industry’s image issue. Companies can overestimate price due to internal biases, use of inappropriate analogues, avoidance of in-country details and the focus on regulatory endpoints at the expense of payer-relevant endpoints. Indeed, fast to label is not necessarily fast to patient access. Given the dominant role price plays in enterprise valuation, the panel today will discuss the key pricing issues, including optimism bias, ways to mitigate these risks and why payer research isn’t always the best answer. Participants will leave with a better understanding of how to optimize pricing and access estimates and improve the quality of engagement with investors, stakeholders and partners as a result.

You can meet us at these conferences and associations:

Our publications

Alliance for Regenerative Medicine White Paper Series

Past speaking engagements:

Alliance for Regenerative Medicine White Paper Series

  • BIO-CEO―Gene therapy panels
  • Jefferies Gene Therapy Conference
  • Duke-Margolis
  • OECD

We have a multilingual staff of native German, French, Italian, Spanish, Portuguese and English speakers who have negotiated on behalf of our clients. A quality that is unique in the industry; that’s what we do.